As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to apply to a newly established review board for approval. Once its treatment is rubber-stamped, the…
Learn why building scalable systems and empowering the right teams can help entrepreneurs avoid growing pains and set their businesses up for long-term success.
We’re starting to give AI agents real autonomy, but are we prepared for what could happen next? This subscriber-only eBook explores this and angles from experts, such as “If we continue on the current path … we are basically playing Russian roulette with humanity.” by Grace Huckins June 12, 2025 Related Stories: Access all subscriber-only…